Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a shorter insomnia therapy boost both sleep and brainpower?

NCT ID NCT06600516

Symptom relief Sponsor: Idaho State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a modified version of Cognitive Behavioral Therapy for Insomnia (CBTi) to see if it can improve sleep and thinking in adults with insomnia. About 37 participants will receive the therapy and be monitored for changes in sleep quality and cognitive function. The goal is to find the simplest effective treatment to make CBTi easier to access and use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

37 people

The number who actually took part.

Started

Sep 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 18 years of age; * Seeking treatment for an insomnia complaint, assessed by self-report; * Probable insomnia disorder, assessed by the SCI, total score ≤ 16; * Stable on any prescribed, non-sedating medications (≥ 1 month), assessed by self-report and structured clinical interview; * Access to an Apple iPhone or iPad (iOS needed for daily sleep diaries app) Exclusion Criteria: * Inability to speak and read English; * Moderate to severe brain damage/cognitive impairment, assessed by the MoCA. total score \< 18; * Inability to follow research protocol (e.g., cannot attend weekly therapy sessions, no-show for appointments, consistent failure to complete assessments, unwillingness to do home sleep study); * Refraining from participation in other behavioral health treatment or medication(s) during participation (unless prescribed/referred by provider); * High risk for suicide within the past 3 months, assessed by C-SSRS * Diagnosed with a serious mental illness (i.e., psychotic disorder, bipolar disorder); * Current pregnancy, assessed by self-report, because sleep disturbances due to pregnancy may be the result of different processes; * Other untreated sleep disorders (e.g., sleep apnea), assessed by clinical interview. (Participants meeting criteria for a sleep disorder requiring intervention will be referred for care through the local Medical Centers or their preferred sleep disorders center.); * Residence \>30 min driving time from university campus

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive functioning are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive functioning Insomnia disorder

Contacts and locations

Locations

  • Idaho State University Psychology Clinic

    Pocatello, Idaho, 83201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.